We use cookies for a better user experience. Read our Privacy Policy
I Agree
In Vitro Diagnostics Market
Analysts’ Viewpoint on Global Market Scenario
The ongoing COVID-19 pandemic has created an unprecedented demand for molecular and antigen tests. Apart from the discovery of new forms of tumors in the human body, the high rate of morbidity & mortality for known tumors among the masses has transcended as a challenge for the healthcare sector. Hence, market stakeholders should collaborate with researchers to improve early detection of tumors in order to reduce morbidity & mortality of patients. Moreover, the increase in global health care expenditure, owing to the rise in disposable income is expected to propel the growth of the market for in vitro diagnostics. Rise in the healthcare expenditure due to the increase in awareness about various healthcare programs and availability of cost-effective diagnostic methods are likely to augment the growth of the global in vitro diagnostics market.
New innovative technologies such as RT-PCR (Reverse Transcription – Polymerase Chain Reaction) and next-generation sequencing provide a comparatively less expensive way of diagnosis, prognosis, and therapy selection in patients throughout their treatment plan. This helps physicians frame appropriate therapeutic regimes for patients suffering from diseases. Such trends are contributing to the growth of the in vitro diagnostics market. The rise in demand for point-of-care (POC) services is likely to drive the IVD market. Point-of-care provides quick and accurate results compared to traditional methods.
In vitro diagnostics can detect diseases or other conditions, and can be used to monitor a person’s overall health to help cure, treat, or prevent diseases. In vitro diagnostics could also be used in precision medicine to identify patients who are likely to benefit from specific treatments or therapies. These in vitro diagnostics can include next-generation sequencing tests, which scan a person’s DNA to detect genomic variations.
Request a sample to get extensive insights into the In Vitro Diagnostics Market
The rising incidence of infectious diseases is playing an important role in the growth of the market for in vitro diagnostics (IVD). The outbreak of the COVID-19 pandemic has led to investments in new research lines for the diagnostics and treatment of infectious diseases. The medical industry has tasted some success in developing resilient diagnostic technologies for COVID-19. However, there is a long way ahead for the medical and healthcare sectors.
As new research lines emerge for the management of the pandemic, the global in-vitro diagnostics market would grow at a steady pace. Furthermore, there has been an increase in the number of cases of COVID-19 and its variants. This factor has also played an underhanded role in driving demand for in vitro diagnostic tests. The analysis of blood samples has gained relevance across several verticals of the healthcare sector.
To understand how our report can bring a difference to your business strategy, Ask for a brochure
The use of in vitro testing in North America has increased at a noticeable pace. This can be attributed to the steep rise in the number of COVID-19 cases across the U.S. Several Asia Pacific countries have also joined hands to deal with the rising incidence of various communicable and non-communicable diseases. This has given an impetus to the growth of the Asia Pacific in vitro diagnostics market. The marked rise in the number of cases of cancer and lung disorders is likely to aid in market expansion in several regions.
The vendors operating in the global in vitro diagnostics (IVD) market are making deliberate efforts to educate people about the relevance of testing and sample collection. The quest of these vendors to capture new domains within the domain of healthcare is expected to drive demand within the global market.
Stuck in a neck-to-neck competition with other brands? Request a custom report on In Vitro Diagnostics Market
Companies in the in vitro diagnostics business are increasing R&D in the testing of infectious diseases, drug testing, oncology, autoimmune diseases, and metabolic diseases, among others. The unprecedented demand for improved diagnostics in the field of oncology is anticipated to drive the demand within the market. In addition, the discovery of new forms of tumors in the human body has raised concerns across the healthcare sector.
Besides, the rising occurrence of known tumors among the masses has transcended as a challenge for the healthcare sector. Therefore, the quest of the healthcare industry to resolve the growing incidence of various types of cancers is projected to fuel the growth of the global IVD market. Furthermore, the collection of samples for biopsies and other similar tests has also supported market maturity. The next few years would be crucial in understanding the direction of growth for the in vitro diagnostics market. The revolutionary growth of the diagnostics domain could prove to be a game changer for market vendors.
|
Attribute |
Detail |
|
Market Size Value in 2020 (Base Year) |
US$ 70.51 Bn |
|
Market Forecast Value in 2028 |
US$ 115.43 Bn |
|
Growth Rate (CAGR) |
6.3% |
|
Forecast Period |
2017–2028 |
|
Quantitative Units |
US$ Mn for Value |
|
Market Analysis |
It includes cross-segment analysis at the regional level. Moreover, the qualitative analysis includes drivers, restraints, opportunities, key trends, pricing analysis, and parent industry overview. |
|
Format |
Electronic (PDF) |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
In Vitro Diagnostics Market – Segmentation
TMR’s study on the global IVD market includes information divided into four segments: technology type, application, end-user, and region. Changing industry trends and other market dynamics associated with these segments of the global in vitro diagnostics (IVD) market are discussed in detail.
| Technology Type |
|
| Application |
|
| End-user |
|
| Region |
|
The global in vitro diagnostics (IVD) market was worth US$ 70.51 Bn and is projected to reach a value of US$ 115.43 Bn by the end of 2028
The global market for In vitro diagnostics is anticipated to grow at a CAGR of 6.3% during the forecast period
North America accounted for a major share of the global in vitro diagnostics business
The market for In vitro diagnostics is driven by a rise in the prevalence of these infectious diseases and is likely to increase the demand for diagnostic tests, which in turn is projected to propel the global market
Key players in the global IVD market include F. Hoffmann-La Roche Ltd., Danaher, Siemens Healthineers, bioMérieux SA, Abbott, Diasorin, Meridian Bioscience, Inc., Ortho-Clinical Diagnostics, Inc., Thermo Fisher Scientific, Inc., and Sysmex Corporation
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global In Vitro Diagnostics Market
4. Market Overview
4.1. Introduction
4.1.1. Application Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global In Vitro Diagnostics Market Analysis and Forecast, 2017–2028
4.4.1. Market Revenue Projections (US$ Mn)
4.4.2. Market Volume/Unit Shipments Projections
4.5. Porter’s Five Force Analysis
5. Key Insights
5.1. Key Mergers and Acquisition
5.2. Key Success Factor for Top 3 Players
5.3. Regulatory Scenario
5.4. Technology Assessment
6. Global In Vitro Diagnostics Market Analysis and Forecast, by Application
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value & Volume Forecast, by Application, 2017–2028
6.3.1. Drug Testing
6.3.2. Infectious Diseases
6.3.3. Oncology
6.3.4. Metabolic Diseases
6.3.5. Autoimmune Diseases
6.3.6. Others
6.4. Market Attractiveness Analysis, by Application
7. Global In Vitro Diagnostics Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value & Volume Forecast, by End-user, 2017–2028
7.3.1. Diagnostic Laboratories
7.3.2. Hospitals
7.3.3. Academic & Research Centers
7.3.4. Home Care
7.3.5. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global In Vitro Diagnostics Market Analysis and Forecast, by Technology Type
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value & Volume Forecast, by Technology Type, 2017–2028
8.3.1. Point-of-care
8.3.2. Molecular Diagnostics
8.3.3. Immunoassays
8.3.4. Clinical Chemistry
8.3.5. Whole Blood Glucose Monitoring
8.3.6. Hematology
8.3.7. Clinical Microbiology
8.3.8. Coagulation & Hemostasis
8.3.9. Others
8.4. Market Attractiveness Analysis, by Technology Type
9. Global In Vitro Diagnostics Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value & Volume Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America In Vitro Diagnostics Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value & Volume Forecast, by Application, 2017–2028
10.2.1. Drug Testing
10.2.2. Infectious Diseases
10.2.3. Oncology
10.2.4. Metabolic Diseases
10.2.5. Autoimmune Diseases
10.2.6. Others
10.3. Market Value & Volume Forecast, by End-user, 2017–2028
10.3.1. Diagnostic Laboratories
10.3.2. Hospitals
10.3.3. Academic & Research Centers
10.3.4. Home Care
10.3.5. Others
10.4. Market Value & Volume Forecast, by Technology Type, 2017–2028
10.4.1. Point-of-care
10.4.2. Molecular Diagnostics
10.4.3. Immunoassays
10.4.4. Clinical Chemistry
10.4.5. Whole Blood Glucose Monitoring
10.4.6. Hematology
10.4.7. Clinical Microbiology
10.4.8. Coagulation & Hemostasis
10.4.9. Others
10.5. Market Value & Volume Forecast, by Country, 2017–2028
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Application
10.6.2. By End-user
10.6.3. By Technology Type
10.6.4. By Country
11. Europe In Vitro Diagnostics Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value & Volume Forecast, by Application, 2017–2028
11.2.1. Drug Testing
11.2.2. Infectious Diseases
11.2.3. Oncology
11.2.4. Metabolic Diseases
11.2.5. Autoimmune Diseases
11.2.6. Others
11.3. Market Value & Volume Forecast, by End-user, 2017–2028
11.3.1. Diagnostic Laboratories
11.3.2. Hospitals
11.3.3. Academic & Research Centers
11.3.4. Home Care
11.3.5. Others
11.4. Market Value & Volume Forecast, by Technology Type, 2017–2028
11.4.1. Point-of-care
11.4.2. Molecular Diagnostics
11.4.3. Immunoassays
11.4.4. Clinical Chemistry
11.4.5. Whole Blood Glucose Monitoring
11.4.6. Hematology
11.4.7. Clinical Microbiology
11.4.8. Coagulation & Hemostasis
11.4.9. Others
11.5. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Application
11.6.2. By End-user
11.6.3. By Technology Type
11.6.4. By Country/Sub-region
12. Asia Pacific In Vitro Diagnostics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value & Volume Forecast, by Application, 2017–2028
12.2.1. Drug Testing
12.2.2. Infectious Diseases
12.2.3. Oncology
12.2.4. Metabolic Diseases
12.2.5. Autoimmune Diseases
12.2.6. Others
12.3. Market Value & Volume Forecast, by End-user, 2017–2028
12.3.1. Diagnostic Laboratories
12.3.2. Hospitals
12.3.3. Academic & Research Centers
12.3.4. Home Care
12.3.5. Others
12.4. Market Value & Volume Forecast, by Technology Type, 2017–2028
12.4.1. Point-of-care
12.4.2. Molecular Diagnostics
12.4.3. Immunoassays
12.4.4. Clinical Chemistry
12.4.5. Whole Blood Glucose Monitoring
12.4.6. Hematology
12.4.7. Clinical Microbiology
12.4.8. Coagulation & Hemostasis
12.4.9. Others
12.5. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Application
12.6.2. By End-user
12.6.3. By Technology Type
12.6.4. By Country/Sub-region
13. Latin America In Vitro Diagnostics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value & Volume Forecast, by Application, 2017–2028
13.2.1. Drug Testing
13.2.2. Infectious Diseases
13.2.3. Oncology
13.2.4. Metabolic Diseases
13.2.5. Autoimmune Diseases
13.2.6. Others
13.3. Market Value & Volume Forecast, by End-user, 2017–2028
13.3.1. Diagnostic Laboratories
13.3.2. Hospitals
13.3.3. Academic & Research Centers
13.3.4. Home Care
13.3.5. Others
13.4. Market Value & Volume Forecast, by Technology Type, 2017–2028
13.4.1. Point-of-care
13.4.2. Molecular Diagnostics
13.4.3. Immunoassays
13.4.4. Clinical Chemistry
13.4.5. Whole Blood Glucose Monitoring
13.4.6. Hematology
13.4.7. Clinical Microbiology
13.4.8. Coagulation & Hemostasis
13.4.9. Others
13.5. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Application
13.6.2. By End-user
13.6.3. By Technology Type
13.6.4. By Country/Sub-region
14. Middle East & Africa In Vitro Diagnostics Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value & Volume Forecast, by Application, 2017–2028
14.2.1. Drug Testing
14.2.2. Infectious Diseases
14.2.3. Oncology
14.2.4. Metabolic Diseases
14.2.5. Autoimmune Diseases
14.2.6. Others
14.3. Market Value & Volume Forecast, by End-user, 2017–2028
14.3.1. Diagnostic Laboratories
14.3.2. Hospitals
14.3.3. Academic & Research Centers
14.3.4. Home Care
14.3.5. Others
14.4. Market Value & Volume Forecast, by Technology Type, 2017–2028
14.4.1. Point-of-care
14.4.2. Molecular Diagnostics
14.4.3. Immunoassays
14.4.4. Clinical Chemistry
14.4.5. Whole Blood Glucose Monitoring
14.4.6. Hematology
14.4.7. Clinical Microbiology
14.4.8. Coagulation & Hemostasis
14.4.9. Others
14.5. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Application
14.6.2. By End-user
14.6.3. By Technology Type
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2020
15.3. Market Footprint Analysis
15.3.1. By Region
15.3.2. By Application Type
15.4. Competitive Business Strategies
15.5. Company Profiles
15.5.1. Competition Matrix
15.5.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.1.2. Product Portfolio
15.5.1.3. SWOT Analysis
15.5.1.4. Strategic Overview
15.5.2. F. Hoffmann-La Roche Ltd.
15.5.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.2.2. Product Portfolio
15.5.2.3. SWOT Analysis
15.5.2.4. Strategic Overview
15.5.3. Danaher
15.5.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.3.2. Product Portfolio
15.5.3.3. SWOT Analysis
15.5.3.4. Strategic Overview
15.5.4. Siemens Healthineers
15.5.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.4.2. Product Portfolio
15.5.4.3. SWOT Analysis
15.5.4.4. Strategic Overview
15.5.5. bioMérieux SA
15.5.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.5.2. Product Portfolio
15.5.5.3. SWOT Analysis
15.5.5.4. Strategic Overview
15.5.6. Abbott
15.5.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.6.2. Product Portfolio
15.5.6.3. SWOT Analysis
15.5.6.4. Strategic Overview
15.5.7. Diasorin
15.5.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.7.2. Product Portfolio
15.5.7.3. SWOT Analysis
15.5.7.4. Strategic Overview
15.5.8. Meridian Bioscience, Inc.
15.5.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.8.2. Product Portfolio
15.5.8.3. SWOT Analysis
15.5.8.4. Strategic Overview
15.5.9. Ortho-Clinical Diagnostics, Inc.
15.5.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.9.2. Product Portfolio
15.5.9.3. SWOT Analysis
15.5.9.4. Strategic Overview
15.5.10. Thermo Fisher Scientific, Inc.
15.5.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.10.2. Product Portfolio
15.5.10.3. SWOT Analysis
15.5.10.4. Strategic Overview
15.5.11. Sysmex Corporation
15.5.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.11.2. Product Portfolio
15.5.11.3. SWOT Analysis
15.5.11.4. Strategic Overview
15.5.12. Other Prominent Players
15.5.12.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.12.2. Product Portfolio
15.5.12.3. SWOT Analysis
15.5.12.4. Strategic Overview
List of Table
Table 01: Global In Vitro Diagnostics Market Size (US$ Mn) and Volume (Units) Forecast, by Technology Type, 2021–2028
Table 02: Global In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Molecular Diagnostics Type, 2021–2028
Table 03: Global In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Immunoassays Type, 2021–2028
Table 04: Global In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Clinical Chemistry Type, 2021–2028
Table 05: Global In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Application, 2021–2028
Table 06: Global In Vitro Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2021–2028
Table 07: Global In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Region, 2021–2028
Table 08: North America In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Country 2021–2028
Table 09: North America In Vitro Diagnostics (US$ Mn) Forecast, by Technology Type, 2021–2028
Table 10: North America In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Molecular Diagnostics Type, 2021–2028
Table 11: America In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Immunoassays Type, 2021–2028
Table 12: North America In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Clinical Chemistry Type, 2021–2028
Table 13: North America In Vitro Diagnostics (US$ Mn) Forecast, by Application, 2021–2028
Table 14: North America In Vitro Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2021–2028
Table 15: Europe In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Country/Region, 2021–2028
Table 16: Europe In Vitro Diagnostics (US$ Mn) Forecast, by Technology Type, 2021–2028
Table 17: Europe In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Molecular Diagnostics Type, 2021–2028
Table 18: Europe In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Immunoassays Type, 2021–2028
Table 19: Europe In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Clinical Chemistry Type, 2021–2028
Table 20: Europe In Vitro Diagnostics (US$ Mn) Forecast, by Application, 2021–2028
Table 21: Europe In Vitro Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2021–2028
Table 22: Asia Pacific In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Country/Region, 2021–2028
Table 23: Asia Pacific In Vitro Diagnostics (US$ Mn) Forecast, by Technology Type, 2021–2028
Table 24: Asia Pacific In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Molecular Diagnostics Type, 2021–2028
Table 25: Asia Pacific In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Immunoassays Type, 2021–2028
Table 26: Asia Pacific In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Clinical Chemistry Type, 2021–2028
Table 27: Asia Pacific In Vitro Diagnostics (US$ Mn) Forecast, by Application, 2021–2028
Table 28: Asia Pacific In Vitro Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2021–2028
Table 29: Latin America In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Country/Region, 2021–2028
Table 30: Latin America In Vitro Diagnostics (US$ Mn) Forecast, by Technology Type, 2021–2028
Table 31: Latin America In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Molecular Diagnostics Type, 2021–2028
Table 32: Latin America In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Immunoassays Type, 2021–2028
Table 33: Latin America In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Clinical Chemistry Type, 2021–2028
Table 34: Latin America In Vitro Diagnostics (US$ Mn) Forecast, by Application, 2021–2028
Table 35: Latin America In Vitro Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2021–2028
Table 36: Middle East & Africa In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Country/Region, 2021–2028
Table 37: Middle East & Africa In Vitro Diagnostics (US$ Mn) Forecast, by Technology Type, 2021–2028
Table 38: Middle East & Africa In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Molecular Diagnostics Type, 2021–2028
Table 39: Middle East & Africa In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Immunoassays Type, 2021–2028
Table 40: Middle East & Africa In Vitro Diagnostics Market Size (US$ Mn) Forecast, by Clinical Chemistry Type, 2021–2028
Table 41: Middle East & Africa In Vitro Diagnostics (US$ Mn) Forecast, by Application, 2021–2028
Table 42: Middle East & Africa In Vitro Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2021–2028
List of Figures
Figure 01: Global In Vitro Diagnostics Market Size (US$ Mn) Forecast, 2021–2028
Figure 02: Global In Vitro Diagnostics Market Value Share Analysis by Technology Type, 2021 and 2028
Figure 03: Global In Vitro Diagnostics Market Value (US$ Mn) and Y-o-Y Growth, by Point-of-Care, 2017–2028
Figure 04: Global In Vitro Diagnostics Market Value (US$ Mn) and Y-o-Y Growth, by Molecular Diagnostics, 2017–2028
Figure 05: Global In Vitro Diagnostics Market Value (US$ Mn) and Y-o-Y Growth, by Immunoassays, 2017–2028
Figure 06: Global In Vitro Diagnostics Market Value (US$ Mn) and Y-o-Y Growth, by Clinical Chemistry, 2017–2028
Figure 07: Global In Vitro Diagnostics Market Value (US$ Mn) and Y-o-Y Growth, by Whole Blood Glucose Monitoring, 2017–2028
Figure 08: Global In Vitro Diagnostics Market Value (US$ Mn) and Y-o-Y Growth, by Hematology, 2017–2028
Figure 09: Global In Vitro Diagnostics Market Value (US$ Mn) and Y-o-Y Growth, by Clinical Microbiology, 2017–2028
Figure 10: Global In Vitro Diagnostics Market Value (US$ Mn) and Y-o-Y Growth, by Coagulation & Hemostasis, 2017–2028
Figure 11: Global In Vitro Diagnostics Market Value (US$ Mn) and Y-o-Y Growth, by Others, 2017–2028
Figure 12: Global In Vitro Diagnostics Market Attractiveness Analysis, by Technology Type, 2021-2028
Figure 13: Global In Vitro Diagnostics Market Value Share Analysis, by Application, 2021 and 2028
Figure 14: Global In Vitro Diagnostics Market Value (US$ Mn) and Y-o-Y Growth, by Drug Testing, 2017–2028
Figure 15: Global In Vitro Diagnostics Market Value (US$ Mn) and Y-o-Y Growth, by Infectious Diseases, 2017–2028
Figure 16: Global In Vitro Diagnostics Market Value (US$ Mn) and Y-o-Y Growth, by Oncology, 2017–2028
Figure 17: Global In Vitro Diagnostics Market Value (US$ Mn) and Y-o-Y Growth, by Metabolic Diseases, 2017–2028
Figure 18: Global In Vitro Diagnostics Market Value (US$ Mn) and Y-o-Y Growth, by Autoimmune Diseases, 2017–2028
Figure 19: Global In Vitro Diagnostics Market Value (US$ Mn) and Y-o-Y Growth, by Others, 2017–2028
Figure 20: Global In Vitro Diagnostics Market Attractiveness Analysis, by End-user, 2021-2028
Figure 21: Global In Vitro Diagnostics Market Value Share Analysis by End-user, 2021 and 2028
Figure 22: Global In Vitro Diagnostics Market Value (US$ Mn) and Y-o-Y Growth, by Diagnostic Laboratories, 2017–2028
Figure 23: Global In Vitro Diagnostics Market Value (US$ Mn) and Y-o-Y Growth, by Hospitals, 2017–2028
Figure 24: Global In Vitro Diagnostics Market Value (US$ Mn) and Y-o-Y Growth, by Academic & Research Centers, 2017–2028
Figure 25: Global In Vitro Diagnostics Market Value (US$ Mn) and Y-o-Y Growth, by Home Care, 2017–2028
Figure 26: Global In Vitro Diagnostics Market Value (US$ Mn) and Y-o-Y Growth, by Others, 2017–2028
Figure 27: Global In Vitro Diagnostics Market Attractiveness Analysis, by End-user, 2021-2028
Figure 28: Global In Vitro Diagnostics Market Value Share Analysis, by Region, 2021 and 2028
Figure 29: Global In Vitro Diagnostics Market Attractiveness Analysis, by Region, 2021-2028
Figure 30: North America In Vitro Diagnostics Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2028
Figure 31: North America In Vitro Market Attractiveness Analysis, by Country, 2021–2028
Figure 32: North America Market Value Share Analysis, by Country, 2021 and 2028
Figure 33: North America In Vitro Diagnostics Market Value Share Analysis, by Technology Type, 2021 and 2028
Figure 34: North America In Vitro Diagnostics Market Value Share Analysis, by Application, 2021 and 2028
Figure 35: North America In Vitro Diagnostics Market Value Share Analysis, by End-user, 2021 and 2028
Figure 36: Europe In Vitro Diagnostics Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2028
Figure 37: Europe In Vitro Market Attractiveness Analysis, by Country/Region, 2021–2028
Figure 38: Europe Market Value Share Analysis by Country/Region, 2021 and 2028
Figure 39: Europe In Vitro Diagnostics Market Value Share Analysis, by Technology Type, 2021 and 2028
Figure 40: Europe In Vitro Diagnostics Market Value Share Analysis, by Application, 2021 and 2028
Figure 41: Europe In Vitro Diagnostics Market Value Share Analysis, by End-user, 2021 and 2028
Figure 42: Asia Pacific In Vitro Diagnostics Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2028
Figure 43: Asia Pacific In Vitro Market Attractiveness Analysis, by Country/Region, 2021–2028
Figure 44: Asia Pacific Market Value Share Analysis by Country/Region, 2021 and 2028
Figure 45: Asia Pacific In Vitro Diagnostics Market Value Share Analysis, by Technology Type, 2021 and 2028
Figure 46: Asia Pacific In Vitro Diagnostics Market Value Share Analysis, by Application, 2021 and 2028
Figure 47: Asia Pacific In Vitro Diagnostics Market Value Share Analysis, by End-user, 2021 and 2028
Figure 48: Latin America In Vitro Diagnostics Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2028
Figure 49: Latin America In Vitro Market Attractiveness Analysis, by Country/Region, 2021–2028
Figure 50: Latin America Market Value Share Analysis by Country/Region, 2021 and 2028
Figure 51: Latin America In Vitro Diagnostics Market Value Share Analysis, by Technology Type, 2021 and 2028
Figure 52: Latin America In Vitro Diagnostics Market Value Share Analysis, by Application, 2021 and 2028
Figure 53: Latin America In Vitro Diagnostics Market Value Share Analysis, by End-user, 2021 and 2028
Figure 54: Middle East & Africa In Vitro Diagnostics Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2028
Figure 55: Middle East & Africa In Vitro Market Attractiveness Analysis, by Country/Region, 2021–2028
Figure 56: Middle East & Africa Market Value Share Analysis by Country/Region, 2021 and 2028
Figure 57: Middle East & Africa In Vitro Diagnostics Market Value Share Analysis, by Technology Type, 2021 and 2028
Figure 58: Middle East & Africa In Vitro Diagnostics Market Value Share Analysis, by Application, 2021 and 2028
Figure 59: Middle East & Africa In Vitro Diagnostics Market Value Share Analysis, by End-user, 2021 and 2028
Figure 60: Global In Vitro Diagnostics Market Share Analysis, by Company, 2020
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
*86 figures and 60 tables includes